209 related articles for article (PubMed ID: 21415239)
1. Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients.
He XX; Tu SM; Lee MH; Yeung SJ
Ann Oncol; 2011 Dec; 22(12):2640-2645. PubMed ID: 21415239
[TBL] [Abstract][Full Text] [Related]
2. Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.
He X; Esteva FJ; Ensor J; Hortobagyi GN; Lee MH; Yeung SC
Ann Oncol; 2012 Jul; 23(7):1771-80. PubMed ID: 22112968
[TBL] [Abstract][Full Text] [Related]
3. Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
Haring A; Murtola TJ; Talala K; Taari K; Tammela TL; Auvinen A
Scand J Urol; 2017 Feb; 51(1):5-12. PubMed ID: 28084175
[TBL] [Abstract][Full Text] [Related]
4. Impact of diabetes and metformin use on prostate cancer outcome of patients treated with radiation therapy: results from a large institutional database.
Taussky D; Preisser F; Karakiewicz PI; Tilki D; Lambert C; Bahary JP; Delouya G; Wistaff R; Laskine M; Nguyen PV; Durand M; Saad F
Can J Urol; 2018 Oct; 25(5):9509-9515. PubMed ID: 30281009
[TBL] [Abstract][Full Text] [Related]
5. Metformin Use is Associated with Improved Survival for Patients with Advanced Prostate Cancer on Androgen Deprivation Therapy.
Richards KA; Liou JI; Cryns VL; Downs TM; Abel EJ; Jarrard DF
J Urol; 2018 Dec; 200(6):1256-1263. PubMed ID: 29940252
[TBL] [Abstract][Full Text] [Related]
6. Clinical pathological characteristics and prognostic analysis of diabetic women with luminal subtype breast cancer.
Xiao Y; Zhang S; Hou G; Zhang X; Hao X; Zhang J
Tumour Biol; 2014 Mar; 35(3):2035-45. PubMed ID: 24096546
[TBL] [Abstract][Full Text] [Related]
7. Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer.
Paulus JK; Williams CD; Cossor FI; Kelley MJ; Martell RE
Cancer Epidemiol Biomarkers Prev; 2016 Oct; 25(10):1418-1425. PubMed ID: 27496094
[TBL] [Abstract][Full Text] [Related]
8. Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study.
Masoudi FA; Inzucchi SE; Wang Y; Havranek EP; Foody JM; Krumholz HM
Circulation; 2005 Feb; 111(5):583-90. PubMed ID: 15699279
[TBL] [Abstract][Full Text] [Related]
9. Preexisting diabetes, metformin use and long-term survival in patients with prostate cancer.
Linkeviciute-Ulinskiene D; Patasius A; Kincius M; Zabuliene L; Smailyte G
Scand J Urol; 2020 Oct; 54(5):401-407. PubMed ID: 32748714
[TBL] [Abstract][Full Text] [Related]
10. Progression to insulin for patients with diabetes mellitus on dual oral antidiabetic therapy using the US Department of Defense Database.
Rascati K; Richards K; Lopez D; Cheng LI; Wilson J
Diabetes Obes Metab; 2013 Oct; 15(10):901-5. PubMed ID: 23531154
[TBL] [Abstract][Full Text] [Related]
11. Antidiabetic drugs influence molecular mechanisms in prostate cancer.
Pircher A; Zieher M; Eigentler A; Pichler R; Schäfer G; Fritz J; Puhr M; Steiner E; Horninger W; Klocker H; Heidegger I
Cancer Biol Ther; 2018; 19(12):1153-1161. PubMed ID: 30067448
[TBL] [Abstract][Full Text] [Related]
12. Tumor features and survival after radical prostatectomy among antidiabetic drug users.
Joentausta RM; Kujala PM; Visakorpi T; Tammela TL; Murtola TJ
Prostate Cancer Prostatic Dis; 2016 Dec; 19(4):367-373. PubMed ID: 27502739
[TBL] [Abstract][Full Text] [Related]
13. Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existing diabetes mellitus type 2.
Lee SH; Yoon SH; Lee HS; Chung MJ; Park JY; Park SW; Song SY; Chung JB; Bang S
Dig Liver Dis; 2016 Apr; 48(4):435-40. PubMed ID: 26775128
[TBL] [Abstract][Full Text] [Related]
14. Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National Diabetes Program Cohort.
Kim HJ; Lee S; Chun KH; Jeon JY; Han SJ; Kim DJ; Kim YS; Woo JT; Nam MS; Baik SH; Ahn KJ; Lee KW
Medicine (Baltimore); 2018 Feb; 97(8):e0036. PubMed ID: 29465545
[TBL] [Abstract][Full Text] [Related]
15. Comparative risk of major cardiovascular events associated with second-line antidiabetic treatments: a retrospective cohort study using UK primary care data linked to hospitalization and mortality records.
Zghebi SS; Steinke DT; Rutter MK; Emsley RA; Ashcroft DM
Diabetes Obes Metab; 2016 Sep; 18(9):916-24. PubMed ID: 27177784
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer.
Häggström C; Van Hemelrijck M; Zethelius B; Robinson D; Grundmark B; Holmberg L; Gudbjörnsdottir S; Garmo H; Stattin P
Int J Cancer; 2017 Feb; 140(3):611-617. PubMed ID: 27770555
[TBL] [Abstract][Full Text] [Related]
17. Metformin and survival in diabetic patients with breast cancer.
El-Benhawy SA; El-Sheredy HG
J Egypt Public Health Assoc; 2014 Dec; 89(3):148-53. PubMed ID: 25534180
[TBL] [Abstract][Full Text] [Related]
18. Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer.
Bayraktar S; Hernadez-Aya LF; Lei X; Meric-Bernstam F; Litton JK; Hsu L; Hortobagyi GN; Gonzalez-Angulo AM
Cancer; 2012 Mar; 118(5):1202-11. PubMed ID: 21800293
[TBL] [Abstract][Full Text] [Related]
19. Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis.
Zhou JB; Tang X; Han M; Yang J; Simó R
Metabolism; 2020 Aug; 109():154265. PubMed ID: 32446679
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Metformin Use during Docetaxel Chemotherapy on Prostate Cancer Specific and Overall Survival of Diabetic Patients with Castration Resistant Prostate Cancer.
Mayer MJ; Klotz LH; Venkateswaran V
J Urol; 2017 Apr; 197(4):1068-1075. PubMed ID: 27984108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
